Co-Authors
This is a "connection" page, showing publications co-authored by Michael Leo and Sheila Weinmann.
Connection Strength
0.736
-
Validation of a Ductal Carcinoma In Situ Biomarker Profile for Risk of Recurrence after Breast-Conserving Surgery with and without Radiotherapy. Clin Cancer Res. 2020 08 01; 26(15):4054-4063.
Score: 0.186
-
External validation of the EORTC and NCCN bladder cancer recurrence and progression risk calculators in a U.S. community-based health system. Urol Oncol. 2020 02; 38(2):39.e21-39.e27.
Score: 0.180
-
Validation of a Genomic Classifier for Predicting Post-Prostatectomy Recurrence in a Community Based Health Care Setting. J Urol. 2016 06; 195(6):1748-53.
Score: 0.137
-
A Novel Biosignature Identifies Patients With DCIS With High Risk of Local Recurrence After Breast Conserving Surgery and Radiation Therapy. Int J Radiat Oncol Biol Phys. 2023 01 01; 115(1):93-102.
Score: 0.055
-
Predicting risk of multiple levels of recurrence and progression after initial diagnosis of nonmuscle-invasive bladder cancer in a multisite, community-based cohort. Cancer. 2021 02 15; 127(4):520-527.
Score: 0.048
-
The effect of multiple recruitment contacts on response rates and patterns of missing data in a survey of bladder cancer survivors 6 months after cystectomy. Qual Life Res. 2020 Apr; 29(4):879-889.
Score: 0.045
-
Clinical Use Cases for a Tool to Assess Risk in Superficial Bladder Cancer. Perm J. 2019; 23.
Score: 0.044
-
Factors That Influence Selectionof Urinary Diversion Among Bladder Cancer Patients in 3 Community-based Integrated Health Care Systems. Urology. 2019 Mar; 125:222-229.
Score: 0.042